Can Pot Extend Ted Kennedy's Life? Too Bad It's Illegal
Share and save this post:
AlterNet Social Networks:
Belief:
Nobel Laureate Slams the Bible, Calls It "A Catalogue of Cruelties"
Mario de Queiroz
Corporate Accountability and WorkPlace:
As Foreclosure Nightmares Increase, Will More Homeowners Pay Off Their Bankers in Violence?
Scott Thill
DrugReporter:
Lies About Marijuana Drive People to a Much More Harmful Drug -- Booze
Steve Fox
Environment:
Why Max Baucus' 'No' Vote on the Climate Bill May Really Help Its Passage
Jeff Mcmahon
Food:
Despite Censorship By Beef Magnate, Michael Pollan Spreads Message About the Real Price of Cheap Food
Health and Wellness:
Do We Really Want to Enshrine Insurance Monopoly into Law? This and 5 Other Complaints About the Health Bill
John Nichols
Immigration:
NYC Marathon Raises Question of Who Is American Enough?
James E. Johnson, Jr.
Media and Technology:
How Biased Media Can Brainwash You
Melinda Burns
Movie Mix:
The Yes Men: Pranksters Out to Fix the World
Mark Engler
Politics:
4 Ways the Stupak Amendment Deprives Women of Access to Abortion
Jessica Arons
Reproductive Justice and Gender:
Fetus-Shaped Potatoes? Going Undercover Inside the Weird World of Right-Wing Abortion Foes
Ann Neumann
Rights and Liberties:
"My Kids Want to Hide Their Identity; They're Scared Someone Will Attack Us": U.S. Muslims Being Targeted
Jaisal Noor
Sex and Relationships:
Instant Sex: Has the Digital Age Destroyed Relationships or Made Them Better?
Vanessa Richmond
Take Action:
G-20 Meetings: Nothing Much Happened in the Suites, and There Was Too Much Punch in the Streets
Laura Flanders
Water:
Why Natural Gas Is Not a Clean Energy Panacea
Stan Cox
World:
With Unemployment at 40 Percent, Afghan Teens Enlist in Army, Police
Lal Aqa Sherin
In the 14 years I've worked in marijuana law reform, few events have struck me as so needlessly tragic as the federal government's consistent and deliberate stifling of medical cannabis research. Nowhere is the Fed's refusal to allow this science more overt and inhumane than as it pertains to the investigation of cannabinoids as anti-cancer agents, particularly in the treatment of gliomas.
As noted in today's wire stories regarding Sen. Edward Kennedy's diagnosis, glioma is an aggressive form of cancer that affects an estimated 10,000 Americans annually. Standard treatments for the cancer include radiation and chemotherapy, though neither procedure has proven particularly effective -- the disease kills approximately half its victims within one year and all within three years.
But what if there was an alternative treatment for gliomas that could selectively target the cancer while leaving healthy cells intact? And what if federal bureaucrats were aware of this treatment, but deliberately withheld this information from the public?
Sadly, the above questions are not hypothetical. As I originally wrote in a 2004 essay for Alternet.org, titled Pot Shows Promise as a Cancer Cure":
In fact, the first experiment documenting pot's anti-tumor effects took place in 1974 at the Medical College of Virginia at the behest of the U.S. government. The results of that study, reported in an Aug. 18, 1974, Washington Post newspaper feature, were that marijuana's psychoactive component, THC, "slowed the growth of lung cancers, breast cancers and a virus-induced leukemia in laboratory mice, and prolonged their lives by as much as 36 percent."
Despite these favorable preliminary findings, U.S. government officials banished the study and refused to fund any follow-up research until conducting a similar -- though secret -- clinical trial in the mid-1990s. That study, conducted by the U.S. National Toxicology Program to the tune of $2 million, concluded that mice and rats administered high doses of THC over long periods had greater protection against malignant tumors than untreated controls.
However, rather than publicize their findings, government researchers shelved the results, which only became public after a draft copy of its findings were leaked in 1997 to a medical journal which in turn forwarded the story to the national media.
In the years since the completion of the National Toxicology trial, the U.S. government has yet to fund a single additional study examining the drug's potential anti-cancer properties. Is this a case of federal bureaucrats putting politics over the health and safety of patients? You be the judge.
See more stories tagged with: medical marijuana, ted kennedy, giloma
Paul Armentano is the deputy director for the NORML Foundation in Washington, D.C.
Liked this story? Get top stories in your inbox each week from AlterNet! Sign up now »
Support AlterNet
Do you value the information you're getting from AlterNet? Please show your support with a tax-deductible donation.
Feedback
Tell us how we're doing.
EMAIL
PRINT
103 COMMENTS
